MUMBAI, India, Nov. 7 -- Intellectual Property India has published a patent application (202517029947 A) filed by FMC Corporation, Philadelphia, on March 28, for 'storage-stable compositions including bixlozone and b eflub ut amid.'
Inventor(s) include Palanicham Y, Krishnan; Sato, Takahiro; Oddos, Thierry; Hourihane, Jonathan; Irvine, Alan D.; and Insel, Richard A.
The application for the patent was published on Nov. 7, under issue no. 45/2025.
According to the abstract released by the Intellectual Property India: "A method to predict a propensity of an infant to develop atopic dermatitis. The method includes observing the expression of S100A8/A9 on a skin area of an infant; comparing the expression to determined standard, wherein the determined standard is ascertained by measuring a level of the biomarker in a subject or pool of subjects who have demonstrated an absence of atopic dermatitis; and determining the propensity of an infant to develop atopic dermatitis, wherein an increase in the expression as compared to the determined standard indicates propensity of the infant to develop atopic dermatitis."
The patent application was internationally filed on Sept. 28, 2023, under International application No.PCT/IB2023/059717.
Disclaimer: Curated by HT Syndication.
